Cited by

• Oral phenytoin pharmacokinetics during omeprazole therapy.

  Prichard PJ, Walt RP, Kitchingman GK, Somerville KW, Langman MJ, Williams J, Richens A. Prichard PJ, et al. Br J Clin Pharmacol. 1987 Oct;24(4):543-5. doi: 10.1111/j.1365-2125.1987.tb03209.x. Br J Clin Pharmacol. 1987. PMID: 3689634 Free PMC article. Clinical Trial.
• Cimetidine interaction with amitriptyline.

  Curry SH, DeVane CL, Wolfe MM. Curry SH, et al. Eur J Clin Pharmacol. 1985;29(4):429-33. doi: 10.1007/BF00613457. Eur J Clin Pharmacol. 1985. PMID: 3912187 Clinical Trial.
• Does H2-receptor antagonist alter the renal function of cyclosporine-treated kidney grafts?

  Inoue S, Sugimoto H, Nagao T, Akiyama N. Inoue S, et al. Jpn J Surg. 1990 Sep;20(5):553-8. doi: 10.1007/BF02471012. Jpn J Surg. 1990. PMID: 2243448
• The influence of cimetidine and ranitidine on the plasma lipid pattern.

  Terruzzi V, Minoli G, Tadeo G, Nespoli M, Rossini A. Terruzzi V, et al. Br J Clin Pharmacol. 1985 Jun;19(6):846-8. doi: 10.1111/j.1365-2125.1985.tb02727.x. Br J Clin Pharmacol. 1985. PMID: 4027127 Free PMC article.
• Calcium antagonists--adverse drug interactions.

  Reicher-Reiss H, Neufeld HN, Ebner FX. Reicher-Reiss H, et al. Cardiovasc Drugs Ther. 1987 Dec;1(4):403-9. doi: 10.1007/BF02209082. Cardiovasc Drugs Ther. 1987. PMID: 2908714 Review.